TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics

Gastric cancer is a leading cause of cancer deaths in the world. The treatment of gastric cancer is challenging because of its highly heterogeneous etiology and clinical characteristics. Recent genomic and molecular characterization of gastric cancer, especially the findings reported by the Cancer G...

Descripción completa

Detalles Bibliográficos
Autor principal: Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2014
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198748/
https://www.ncbi.nlm.nih.gov/pubmed/25223913
http://dx.doi.org/10.5732/cjc.014.10117
_version_ 1782339778408087552
author Zhang, Wei
author_facet Zhang, Wei
author_sort Zhang, Wei
collection PubMed
description Gastric cancer is a leading cause of cancer deaths in the world. The treatment of gastric cancer is challenging because of its highly heterogeneous etiology and clinical characteristics. Recent genomic and molecular characterization of gastric cancer, especially the findings reported by the Cancer Genome Atlas (TCGA), have shed light on the heterogeneity and potential targeted therapeutics for four different subtypes of gastric cancer.
format Online
Article
Text
id pubmed-4198748
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Sun Yat-sen University Cancer Center
record_format MEDLINE/PubMed
spelling pubmed-41987482014-10-20 TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics Zhang, Wei Chin J Cancer Editorial Gastric cancer is a leading cause of cancer deaths in the world. The treatment of gastric cancer is challenging because of its highly heterogeneous etiology and clinical characteristics. Recent genomic and molecular characterization of gastric cancer, especially the findings reported by the Cancer Genome Atlas (TCGA), have shed light on the heterogeneity and potential targeted therapeutics for four different subtypes of gastric cancer. Sun Yat-sen University Cancer Center 2014-10 /pmc/articles/PMC4198748/ /pubmed/25223913 http://dx.doi.org/10.5732/cjc.014.10117 Text en Chinese Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission.
spellingShingle Editorial
Zhang, Wei
TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
title TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
title_full TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
title_fullStr TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
title_full_unstemmed TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
title_short TCGA divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
title_sort tcga divides gastric cancer into four molecular subtypes: implications for individualized therapeutics
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198748/
https://www.ncbi.nlm.nih.gov/pubmed/25223913
http://dx.doi.org/10.5732/cjc.014.10117
work_keys_str_mv AT zhangwei tcgadividesgastriccancerintofourmolecularsubtypesimplicationsforindividualizedtherapeutics

Ejemplares similares